- Telehealth Visits
- Insurance plan information
Tara Lacey, NP, RN
Sarcoma Medical Oncology • Medical Oncology- Telehealth Visits
- Insurance plan information
Tara Lacey, NP, RN
Sarcoma Medical Oncology • Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Tara Lacey is a nurse practitioner who cares for patients with sarcoma (cancer that begin in the bones or the soft tissues), lung cancer and other conditions affecting the lungs, chest or esophagus. She has specialized in caring for patients with cancer for more than 20 years. She is certified as a gerontological nurse practitioner and advanced oncology nurse practitioner.
A native of Ontario, Canada, Lacey earned her bachelor's degree in nursing from the University of Windsor and her master's degree in nursing from UCSF, where she specialized in oncology and geriatric medicine. In addition to California, she has worked in several U.S. states, including Arizona, Oregon and Texas.
Lacey is a published author, speaker and educator on various topics within oncology and hematology, including treatments, supportive care management and survivorship. She is a member of the Oncology Nursing Society and American Society of Clinical Oncology. She serves as an instructor at San Francisco State University.
Education & training
Board certification
- Advanced Oncology Certified NP, Oncology Nursing Certification Corporation
- Gerontological NP, American Nurses Credentialing Center
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221414%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221414%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.